Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Never Discard Rejected Materials in General Trash Bins

Posted on May 13, 2025 By digi

Never Discard Rejected Materials in General Trash Bins

Rejected Materials Must Not Be Thrown into General Waste Bins

Remember: Discarding rejected materials in general trash is a serious GMP violation—use designated, controlled disposal procedures.

Why This Matters in GMP

Rejected pharmaceutical materials, whether due to contamination, deviation, or quality failure, must be handled with utmost care. Disposing of these materials in uncontrolled trash bins increases the risk of misuse, re-entry into production, contamination of other products, and environmental hazards. It undermines traceability and opens the door to product diversion or counterfeiting. GMP requires full accountability for all materials from receipt to disposal. Proper disposal of rejected goods ensures they cannot be mistaken for approved materials and supports a secure supply chain. Disregarding this practice reflects poorly on a facility’s quality culture and can lead to severe consequences during inspections.

Also Read:  How to Achieve GMP Compliance for IMPs in Regulated Markets

Regulatory and Compliance Implications

FDA 21 CFR Part 211.94 and 211.192 require clear identification and proper disposition of rejected materials. WHO GMP and Schedule M emphasize controlled destruction and segregation of non-conforming products. EU GMP mandates secure handling and documentation of rejects to prevent unintended use. Regulatory agencies often inspect waste areas, destruction records, and the flow of rejected materials. Improper disposal is treated as a critical non-compliance issue, possibly resulting in Form 483s or warning letters. All rejected goods must be quarantined, documented, and destroyed under QA supervision, with destruction records traceable and retained for audit purposes.

Implementation Best Practices

  • Designate secure, labeled containers for rejected materials—never mix with general trash.
  • Maintain a rejection log that includes batch numbers, reasons, quantities, and disposition methods.
  • Implement SOPs for rejection handling, including QA approval before destruction.
  • Train staff to immediately segregate rejected goods and report them to QA.
  • Use incineration, shredding, or validated destruction vendors with certificates of disposal.
Also Read:  Avoid Operating Equipment Without Completing Logbook Entries

Regulatory References

  • FDA 21 CFR Part 211.94 – Drug Product Containers and Closures
  • FDA 21 CFR Part 211.192 – Production Record Review
  • WHO GMP – Control of Rejected Products
  • Schedule M – Disposal of Waste and Rejected Materials
  • EU GMP Chapter 5 – Production
GMP Tips Tags:audit readiness, contamination control, controlled waste management, destruction protocol, FDA 21 CFR Part 211, GMP compliance, material rejection, pharmaceutical waste disposal, quality assurance, Regulatory compliance, rejected goods handling, Schedule M, waste segregation, WHO GMP

Post navigation

Previous Post: Maintain Temperature Logs for Cold Chain Pharmaceutical Products
Next Post: Follow Hold Time Studies to Ensure Product Stability and Safety

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog
Widget Image
  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas

    Do Not Stockpile Rejected Units… Read more

GMP Tips

  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas
  • Update GMP Training Records After Every Training Session
  • Never Use Photocopies as Originals for GMP Quality Documents
  • Verify Integrity of Tamper-Evident Seals During Packaging
  • Never Use Trial Batches for Commercial Release Under GMP
  • Conduct Routine Gown Integrity Checks in GMP Cleanrooms
  • Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination
  • Review Equipment Logbooks for Completeness During GMP Audits
  • Never Rely on Memory to Record GMP Observations or Results
  • Follow Hold Time Studies to Ensure Product Stability and Safety

More about GMP Tips :

  • Do Not Record Test Results Before Completing the Analysis
  • Review Equipment Logbooks for Completeness During GMP Audits
  • Never Rely on Memory to Record GMP Observations or Results
  • Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination
  • Follow Hold Time Studies to Ensure Product Stability and Safety
  • Maintain Temperature Logs for Cold Chain Pharmaceutical Products
  • Avoid Operating Equipment Without Completing Logbook Entries
  • Conduct Routine Gown Integrity Checks in GMP Cleanrooms
  • Implement Controlled Access to Data Entry Terminals in GMP Areas
  • Verify Integrity of Tamper-Evident Seals During Packaging
  • Never Replace Approved SOPs with Verbal Instructions in GMP
  • Conduct Periodic Pest Control Audits in GMP Storage Areas
  • Never Approve Batches Without Complete Analytical Test Reports
  • Label In-Process Samples with Date and Initials for Traceability
  • Never Use Photocopies as Originals for GMP Quality Documents

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme